ARCHIVES

Industry Groups Lobby for Lower Standards for FDA Approval

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Still Misperceptions On Hill About CRADA Between NCI, BMS

March 13, 1992

Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs.

April 30, 2004

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

PDQ Now Offers CME Credit to Physician Users

July 3, 1987

In Brief: Gallo, Montagnier, Four Others Share Japan Prize; RPMI, First Cancer Center, 90 Years Old

May 20, 1988

Program Committee Lists 10 Papers At AACR Meeting

July 19, 1985